Review




Structured Review

Sequenom quantitative sequenom massarray
(A) CpG islands in ZNF154. The transcription start site (TSS) is indicated by a curved arrow. The regions analysed by methylation specific PCR (MSP) and <t>MassARRAY</t> are shown. (B) Relative ZNF154 expression in normal nasopharyngeal NP69 cells and NPC cell lines. Glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) was used as the endogenous control. (C) Relative ZNF154 expression in NPC tissues and non-cancer nasopharyngitis biopsy tissues (NCNBT). (D) Western blotting analysis of ZNF154 protein expression in NPC cell lines and NP69 cells. (E) Quantitative MassARRAY methylation analysis of ZNF154 in NP69 cell lines, normal tissues (NT), NPC cell lines and NPC tissue specimens (P). (F) Demethylation treatment with 5-Aza restored the expression of ZNF154 in NPC cell lines. (G) MSP analysis of the methylation status of ZNF154 after demethylation treatment of NPC cell lines; M, methylated allele; U, unmethylated allele.
Quantitative Sequenom Massarray, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/quantitative+sequenom+massarray/pmc05689643-14-14-15
Average 90 stars, based on 1 article reviews
quantitative sequenom massarray - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling"

Article Title: Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling

Journal: Oncotarget

doi: 10.18632/oncotarget.20479

(A) CpG islands in ZNF154. The transcription start site (TSS) is indicated by a curved arrow. The regions analysed by methylation specific PCR (MSP) and MassARRAY are shown. (B) Relative ZNF154 expression in normal nasopharyngeal NP69 cells and NPC cell lines. Glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) was used as the endogenous control. (C) Relative ZNF154 expression in NPC tissues and non-cancer nasopharyngitis biopsy tissues (NCNBT). (D) Western blotting analysis of ZNF154 protein expression in NPC cell lines and NP69 cells. (E) Quantitative MassARRAY methylation analysis of ZNF154 in NP69 cell lines, normal tissues (NT), NPC cell lines and NPC tissue specimens (P). (F) Demethylation treatment with 5-Aza restored the expression of ZNF154 in NPC cell lines. (G) MSP analysis of the methylation status of ZNF154 after demethylation treatment of NPC cell lines; M, methylated allele; U, unmethylated allele.
Figure Legend Snippet: (A) CpG islands in ZNF154. The transcription start site (TSS) is indicated by a curved arrow. The regions analysed by methylation specific PCR (MSP) and MassARRAY are shown. (B) Relative ZNF154 expression in normal nasopharyngeal NP69 cells and NPC cell lines. Glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) was used as the endogenous control. (C) Relative ZNF154 expression in NPC tissues and non-cancer nasopharyngitis biopsy tissues (NCNBT). (D) Western blotting analysis of ZNF154 protein expression in NPC cell lines and NP69 cells. (E) Quantitative MassARRAY methylation analysis of ZNF154 in NP69 cell lines, normal tissues (NT), NPC cell lines and NPC tissue specimens (P). (F) Demethylation treatment with 5-Aza restored the expression of ZNF154 in NPC cell lines. (G) MSP analysis of the methylation status of ZNF154 after demethylation treatment of NPC cell lines; M, methylated allele; U, unmethylated allele.

Techniques Used: Methylation, Expressing, Control, Western Blot

PCR primer sequences
Figure Legend Snippet: PCR primer sequences

Techniques Used: Sequencing, Reverse Transcription, Methylation

Related Articles

Methylation:

Article Title: Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling
Article Snippet: .. The methylation status of ZNF154 in NPC was detected with Methylation specific-PCR (MSP) and Quantitative Sequenom MassARRAY. ..

Article Title: Transient DNMT1 suppression reveals hidden heritable marks in the genome
Article Snippet: .. Using quantitative Sequenom MassArray, the methylation status of various REs (LINE-1, IAP, SINE, Minor Satellite and Gamma Satellite) was determined before and following the pharmacological inactivation of Dnmt1 in our ES cell reprogramming model (Figure and ). ..

Article Title: miR-137 Inhibition of the Invasion, Metastasis, and Epithelial-Mesenchymal Transition of Nasopharyngeal Cancer by Regulating KDM1A
Article Snippet: .. Methylation-specific PCR and quantitative Sequenom MassARRAY were used to determine the methylation status of ZNF154 in NPC. .. Methylation-specific PCR and quantitative Sequenom MassARRAY were used to determine the methylation status of ZNF154 in NPC.

Inactivation:

Article Title: Transient DNMT1 suppression reveals hidden heritable marks in the genome
Article Snippet: .. Using quantitative Sequenom MassArray, the methylation status of various REs (LINE-1, IAP, SINE, Minor Satellite and Gamma Satellite) was determined before and following the pharmacological inactivation of Dnmt1 in our ES cell reprogramming model (Figure and ). ..

DNA Methylation Assay:

Article Title: Disruption of histone methylation in developing sperm impairs offspring health transgenerationally.
Article Snippet: Birth defects occur in three percent of babies and can be caused by genetic factors or environmental exposures with 50% being idiopathic (1, 2).. The focus on prevention has largely been on the mother, despite the father contributing half the genetic information and possibly some epigenetic information to the embryo.. Studies in humans and animals suggest that epigenetic mechanisms may serve in the transmission of environmentally-induced phenotypic traits from parents to offspring (3–8).

Bisulfite Methylation Profiling:

Article Title: Disruption of histone methylation in developing sperm impairs offspring health transgenerationally.
Article Snippet: Birth defects occur in three percent of babies and can be caused by genetic factors or environmental exposures with 50% being idiopathic (1, 2).. The focus on prevention has largely been on the mother, despite the father contributing half the genetic information and possibly some epigenetic information to the embryo.. Studies in humans and animals suggest that epigenetic mechanisms may serve in the transmission of environmentally-induced phenotypic traits from parents to offspring (3–8).

Mass Spectrometry:

Article Title: Disruption of histone methylation in developing sperm impairs offspring health transgenerationally.
Article Snippet: Birth defects occur in three percent of babies and can be caused by genetic factors or environmental exposures with 50% being idiopathic (1, 2).. The focus on prevention has largely been on the mother, despite the father contributing half the genetic information and possibly some epigenetic information to the embryo.. Studies in humans and animals suggest that epigenetic mechanisms may serve in the transmission of environmentally-induced phenotypic traits from parents to offspring (3–8).

Analysis:

Article Title: Disruption of histone methylation in developing sperm impairs offspring health transgenerationally.
Article Snippet: Birth defects occur in three percent of babies and can be caused by genetic factors or environmental exposures with 50% being idiopathic (1, 2).. The focus on prevention has largely been on the mother, despite the father contributing half the genetic information and possibly some epigenetic information to the embryo.. Studies in humans and animals suggest that epigenetic mechanisms may serve in the transmission of environmentally-induced phenotypic traits from parents to offspring (3–8).

Polymerase Chain Reaction:

Article Title: miR-137 Inhibition of the Invasion, Metastasis, and Epithelial-Mesenchymal Transition of Nasopharyngeal Cancer by Regulating KDM1A
Article Snippet: .. Methylation-specific PCR and quantitative Sequenom MassARRAY were used to determine the methylation status of ZNF154 in NPC. .. Methylation-specific PCR and quantitative Sequenom MassARRAY were used to determine the methylation status of ZNF154 in NPC.



Similar Products

96
agena bioscience agena massarray methylation detection
Agena Massarray Methylation Detection, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/Methylation/ppr0552502-125-0-0
Average 96 stars, based on 1 article reviews
agena massarray methylation detection - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Sequenom massarray methylation detection
A A negative correlation between ZNF334 <t>methylation</t> level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
Massarray Methylation Detection, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/massarray+quantitative+methylation+analysis/pmc09085879-231-0-4
Average 90 stars, based on 1 article reviews
massarray methylation detection - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
agena bioscience massarray system methylation detection amplification pcr reaction
A A negative correlation between ZNF334 <t>methylation</t> level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
Massarray System Methylation Detection Amplification Pcr Reaction, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/Methylation/pm31002356-111-8-15
Average 96 stars, based on 1 article reviews
massarray system methylation detection amplification pcr reaction - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
agena bioscience agena massarray system methylation detection amplification pcr reaction
A A negative correlation between ZNF334 <t>methylation</t> level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
Agena Massarray System Methylation Detection Amplification Pcr Reaction, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/Methylation/pm31002356-111-7-15
Average 96 stars, based on 1 article reviews
agena massarray system methylation detection amplification pcr reaction - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

Journal: Cell Death & Disease

Article Title: DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334

doi: 10.1038/s41419-022-04895-6

Figure Lengend Snippet: A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

Article Snippet: MassARRAY methylation detection technology (Sequenom, USA) performed by CapitalBio Technology (Shanghai, China) was used to detect the methylation level of ZNF334 promoter (human) in carcinoma and paracancerous tissues of 25 HCC patients and Zfp334 promoter (mice) in treatment and control group.

Techniques: Methylation, Expressing, Western Blot, Mass Spectrometry, Sequencing